{"name":"Hangzhou Jiuyuan Gene Engineering Co. Ltd.,","slug":"hangzhou-jiuyuan-gene-engineering-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxPM3NDY2ZOeV9lX3luTDNoVnF1MkdWbzFmOG1NMWo0WENTenRaZ2l4MW5ITWZpV3owQXIwSVphM3lKSk8wajRZYTZXRFNIbXg1U2tiUHJQNFVDRHQ2TFNwLXIzQlg5VmlqeVVvZ196NWJReENST3ZheHJpVldoSnhHUnhhSFlLV2dxR3BqdC1n?oc=5","date":"2024-12-03","type":"pipeline","source":"BioWorld News","summary":"Jiuyuan Gene raises HKD$485M in Hong Kong IPO - BioWorld News","headline":"Jiuyuan Gene raises HKD$485M in Hong Kong IPO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxQZFVYS0F6M0RwZWpFek9kVGNVRHBhZS1EWDM0cDVhd2I3X3B1bUlDSHNWV3VKUWlabmYtTjM3ZnVyd01RMnlibnprUmhaUlR1dmM4cGd0T3o1ZVAxcHhSYlpqVEpFX1RaRUdRNVF0UHJmdERvTTlra29JOE03VDhoMUNUUEZiTi1LRkN2VkFubVRMQQ?oc=5","date":"2024-09-17","type":"pipeline","source":"BioWorld News","summary":"China biotechs rise to challenge Ozempic, Wegovy - BioWorld News","headline":"China biotechs rise to challenge Ozempic, Wegovy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxOOXhBZVB6NVJZb2Y3V2tSQ1F1em5uWUd1cWEzTWpGOC1PYUs5ZVBpQmJjXzdSZ3NTYnZUS2JCZVJzQlNSMGdsSmEwNkItVjRyd3piWUtQTVFTaEhDZTZLdmpMVmprcDVBdjg0UDgwMWJjaHVER21Fc3Vwekh6cy1DN2FHZlJBVi16V21VbG5FM01XWVo1c1ZQRXZmVQ?oc=5","date":"2024-09-11","type":"pipeline","source":"BioWorld News","summary":"Big pharma eyes China ‘at forefront of GLP-1 revolution’ - BioWorld News","headline":"Big pharma eyes China ‘at forefront of GLP-1 revolution’","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxOelJQQ3ZNUWhhZm5PRm83cHotbENTUjZYRy0tMkpHSDVBNVhESmVNQnMzeUEtZko4QV9yUm9jY0lRTkE5Y1R5aDVVZTZqajBxZ2NhSXFBSXFMY0xMdHRDSUMwdXRNWHJDcTdGc2dFSHQ5OFVjbHRnSG1TXzB4ZExfZmIwUHViUXVvT3RSU2FfMVlpYTBuZUpBMFdrMjdpUlI4MlFmZA?oc=5","date":"2024-04-11","type":"regulatory","source":"BioWorld News","summary":"China advances semaglutide biosimilars, Jiuyuan seeks NMPA nod - BioWorld News","headline":"China advances semaglutide biosimilars, Jiuyuan seeks NMPA nod","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxPeTNpMHRoenZwaGZ6bWZQTHEzZm1PbllFczRSQmFyQUVfZUJETnZtZWZ6RVp4b2FPMHpkc2gtTFJOVzJOTDN5Q2RhUE45di1tMEhNcml5TGhHS3YtODJLYWpFeUZGeG9qNDUxX2QzOTdxVEJkRHVyYmZnNXRJaWxxamZndVQ5cjBWU1NDbGtHakprSWFFVEhIa0EwNVRCZHVJY2w4blI2eTNQUTc0M1Jwa3pzNnU4ODdtVXdlQVZtMkJuRmJMTVNkVXd5YW1GOWh3dHQ0?oc=5","date":"2024-04-04","type":"patent","source":"Center for Biosimilars","summary":"Eye on Pharma: Biosimilar Ozempic; Celltrion Omalizumab Biosimilar Submission - Center for Biosimilars","headline":"Eye on Pharma: Biosimilar Ozempic; Celltrion Omalizumab Biosimilar Submission","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxQY2pGVVJtVkZhcjlSUFJMSndQWjJEdDVZR21mQlluMkZQMGZnckxKR2xOektYMlhIMEJocGtObXhNT1hESWJmeEtNT21qMmJIbndBRWJ6UEZvbmF1dlN6SlRocnlGQ3lINFNQQW42M1VrR2w3QnU3MmVPbFhhYm4tWUV1aW5HNkluZ24wRmRrWERQVmVrZkhuLUR6bllOUmV2X0tVV2k4dFJUV1dwbF9OUkxKUnFsMlNaWGNpaXNfSHdHRFk?oc=5","date":"2024-04-03","type":"regulatory","source":"Reuters","summary":"Drugmaker seeks approval for China's first biosimilar Ozempic - Reuters","headline":"Drugmaker seeks approval for China's first biosimilar Ozempic","sentiment":"positive"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}